News
ARS Pharmaceuticals' Neffy, an epinephrine nasal spray, is poised as a game-changer for emergency allergies, driving growth.
Snot plays a powerful role in protecting us from disease – and its colour alone can provide insights into what's going on in ...
Shares of Evoke Pharma are trading sharply higher Wednesday morning. The specialty pharma company received a U.S. Patent ...
Opinion
1hon MSNOpinion
For parents of kids with severe food allergies like mine, the rite of passage that is starting primary school is fraught with very real, very deadly fears that they will come to serious harm – or ...
Atai Life Sciences (NASDAQ:ATAI) is one of the best-performing NASDAQ stocks according to analysts. On July 1, Atai Life ...
ACHV's cytisinicline shows best-in-class efficacy and safety for smoking cessation. Click here to find out why ACHV stock is ...
Opinion
Silverman: Trump mocks a Fox News host for her voice. I know the challenge of having a unique voice.Jessica Tarlov’s voice is more than just unique; it’s kind, courageous and desperately needed. Trump's attacks are indecent and brutish ...
This year also brings a shiny new shopping feature: “Today’s Big Deals”—a daily, themed drop of limited-time offers from top ...
2d
InvestorsHub on MSNEvoke Pharma Shares Jump 50% Following Patent Approval for GIMOTIEvoke Pharma Inc (NASDAQ:EVOK) saw its stock soar 50% after the specialty pharma company received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application covering ...
1d
Investor's Business Daily on MSNAcadia Emerges From Behind The Scenes With A Potential $12 Billion OpportunityAcadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results